Russell Investments Group
IHE icon

Russell Investments Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Russell Investments Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6K Sell
188
-253
-57% -$22.8K ﹤0.01% 3820
2026
Q1 		$38.2K Buy
441
+52
+13% +$4.55K ﹤0.01% 3409
2025
Q4 		$33K Buy
389
+71
+22% +$5.67K ﹤0.01% 3455
2025
Q3 		$23.1K Hold
318
– – ﹤0.01% 3554
2025
Q2 		$20.8K Buy
318
+93
+41% +$6.05K ﹤0.01% 3179
2025
Q1 		$15.9K Hold
225
– – ﹤0.01% 3148
2024
Q4 		$14.8K Hold
225
– – ﹤0.01% 3065
2024
Q3 		$15.9K Buy
+225
New +$15.7K ﹤0.01% 3002

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Russell Investments Group's IHE Position: Q2 2026 in Review

Russell Investments Group reduced its iShares US Pharmaceuticals ETF (IHE) stake by 57% in Q2 2026, selling an estimated $22.8K and leaving 188 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3820.

Russell Investments Group first reported a position in IHE in Q3 2024 and has held it in 8 quarters since. The position peaked at $38.2K in Q1 2026. 139 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Russell Investments Group held 188 shares of iShares US Pharmaceuticals ETF worth $18.6K as of Q2 2026.
  • Russell Investments Group sold 253 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $22.8K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3820 holding.
  • Russell Investments Group first reported a position in iShares US Pharmaceuticals ETF in Q3 2024 and has held it in 8 quarters since.
  • Russell Investments Group's iShares US Pharmaceuticals ETF position peaked at $38.2K in Q1 2026.
  • 139 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.